# ATRO Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atro-medical-b-v

- Industry: Medical Devices & Equipment
- Headquarters: Nijmegen, Netherlands
- Website: www.atromedical.com
- Latest round: Series A (Jun 1, 2018)
- Investors on record: 6

## About

ATRO Medical B.V. is a Dutch company specializing in orthopedic solutions, focusing on the development of innovative medical devices designed to address chronic knee pain effectively.Founded in 2016 and headquartered in Nijmegen, Netherlands, ATRO Medical B.V. develops orthopedic solutions, including the Artimis® meniscus prosthesis.  In February 2026, ATRO Medical B.V. raised EUR 3 million in venture funding from 819 Capital Partners, Samaplast AG, Bolwork, Thuja Capital, and DSM Venturing, with a complementary grant funding. The company was founded by individuals with backgrounds in medical device development, although specific founder details are not provided.ATRO Medical specializes in the development of innovative orthopedic solutions, with its flagship product being the Artimis® meniscus prosthesis. This artificial meniscus is engineered to replace damaged or absent menisci in patients with chronic knee pain following a meniscectomy. Composed of non-biodegradable plastic, the Artimis® prosthesis aims to restore knee joint functionality and alleviate pain, enabling patients to return to daily activities, excluding heavy sports. Currently, ATRO Medical is conducting clinical trials across multiple hospitals in the Netherlands, focusing on the effectiveness of the Artimis® meniscus prosthesis and expanding clinical research internationally, demonstrating a commitment to improving treatment options for patients suffering from persistent knee pain. Their primary customer base includes orthopedic surgeons, hospitals, and clinics treating knee-related conditions.ATRO Medical's revenue model revolves around the sale of its proprietary medical device, the Artimis® meniscus prosthesis, through partnerships with healthcare facilities and professionals in the orthopedic field. The company engages in direct business-to-business (B2B) transactions with hospitals and clinics that aim to provide advanced treatment options for their patients. Revenue is generated from the sales of these prostheses, along with potential partnerships and collaborations with research institutions on clinical trials. By fostering long-term relationships with healthcare providers, ATRO Medical enhances its revenue potential and ensures the availability of innovative solutions for chronic knee pain management.The company will use the February 2026 funding to expand clinical evidence generation, prepare for pivotal clinical trials in the US and Europe, and optimize manufacturing, regulatory readiness, and clinical operations.

## Funding rounds

- Series A, Jun 1, 2018 — BOM Brabant Ventures
- Series A, Jan 25, 2018 — Oost NL
- Series A, Jul 11, 2017 — DSM Venturing, Thuja Capital, BOM Brabant Ventures, Cascara Ventures, Radboud University

## Investors

- DSM Venturing (https://capitalatlas.ai/funds/dsm-venturing) — Series A
- Thuja Capital (https://capitalatlas.ai/funds/thuja-capital) — Series A
- BOM Brabant Ventures (https://capitalatlas.ai/funds/bom-brabant-ventures) — Series A
- Cascara Ventures (https://capitalatlas.ai/funds/cascara-ventures) — Series A
- Radboud University — Series A
- Oost NL (https://capitalatlas.ai/funds/oost-nl) — Series A